Dr.Reddy’s has announced the launch of Melphalan Hydrochloride for injection, which has been approved by the United States Food and Drug Administration. This latest product is a therapeutic equivalent generic version of Alkeran.
The company’s Melphalan Hydrochloride for injection is available in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL clear glass vial of sterile diluent.
The Alkeran brand and generic had U.S. sales of approximately $107 million MAT for the most recent twelve months ending in October 2017, according to IQVIA data.
http://www.drugstorenews.com/
